Selected research
Market Analysis & Forecast
Global Drug and Medical Device Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Drug and Medical Device Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Drug and Medical Device Testing include SGS, Beijing Pony Testing Company, GTTC, Shanghai International Certification Assessment Services Co.,Ltd., Guangdong Sino-sci Testing Technology Corporation Limited, GBT, FUDA TESTING GROUP, Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. and Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Drug and Medical Device Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Drug and Medical Device Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug and Medical Device Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug and Medical Device Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug and Medical Device Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug and Medical Device Testing revenue, projected growth trends, production technology, application and end-user industry.
Drug and Medical Device Testing Segment by Company
SGS
Beijing Pony Testing Company
GTTC
Shanghai International Certification Assessment Services Co.,Ltd.
Guangdong Sino-sci Testing Technology Corporation Limited
GBT
FUDA TESTING GROUP
Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
Guangzhou Medicine Industry Research Institute
Drug and Medical Device Testing Segment by Type
Drug Testing
Medical Device Testing
Drug and Medical Device Testing Segment by Application
Pharmaceutical Products Manufacturer
Medical Device Manufacturer
Drug and Medical Device Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug and Medical Device Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug and Medical Device Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug and Medical Device Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Drug and Medical Device Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Drug and Medical Device Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug and Medical Device Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Pharmaceutical Products Manufacturer
- Medical Device Manufacturer
Companies covered
- SGS
- Beijing Pony Testing Company
- GTTC
- Shanghai International Certification Assessment Services Co.,Ltd.
- Guangdong Sino-sci Testing Technology Corporation Limited
- GBT
- FUDA TESTING GROUP
- Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
- Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
- Guangzhou Medicine Industry Research Institute
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Drug and Medical Device Testing Market by Type
- 1.2.1 Global Drug and Medical Device Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Drug Testing
- 1.2.3 Medical Device Testing
- 1.3 Drug and Medical Device Testing Market by Application
- 1.3.1 Global Drug and Medical Device Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Products Manufacturer
- 1.3.3 Medical Device Manufacturer
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Drug and Medical Device Testing Market Dynamics
- 2.1 Drug and Medical Device Testing Industry Trends
- 2.2 Drug and Medical Device Testing Industry Drivers
- 2.3 Drug and Medical Device Testing Industry Opportunities and Challenges
- 2.4 Drug and Medical Device Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Drug and Medical Device Testing Market Perspective (2021-2032)
- 3.2 Global Drug and Medical Device Testing Growth Trends by Region
- 3.2.1 Global Drug and Medical Device Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Drug and Medical Device Testing Market Size by Region (2021-2026)
- 3.2.3 Global Drug and Medical Device Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Drug and Medical Device Testing Revenue by Players
- 4.1.1 Global Drug and Medical Device Testing Revenue by Players (2021-2026)
- 4.1.2 Global Drug and Medical Device Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Drug and Medical Device Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Drug and Medical Device Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Drug and Medical Device Testing Key Players Headquarters & Area Served
- 4.4 Global Drug and Medical Device Testing Players, Product Type & Application
- 4.5 Global Drug and Medical Device Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Drug and Medical Device Testing Market CR5 and HHI
- 4.6.3 2025 Drug and Medical Device Testing Tier 1, Tier 2, and Tier 3
5 Drug and Medical Device Testing Market Size by Type
- 5.1 Global Drug and Medical Device Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Drug and Medical Device Testing Revenue by Type (2021-2032)
- 5.3 Global Drug and Medical Device Testing Revenue Market Share by Type (2021-2032)
6 Drug and Medical Device Testing Market Size by Application
- 6.1 Global Drug and Medical Device Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Drug and Medical Device Testing Revenue by Application (2021-2032)
- 6.3 Global Drug and Medical Device Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 SGS
- 7.1.1 SGS Company Information
- 7.1.2 SGS Business Overview
- 7.1.3 SGS Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 SGS Drug and Medical Device Testing Product Portfolio
- 7.1.5 SGS Recent Developments
- 7.2 Beijing Pony Testing Company
- 7.2.1 Beijing Pony Testing Company Company Information
- 7.2.2 Beijing Pony Testing Company Business Overview
- 7.2.3 Beijing Pony Testing Company Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Beijing Pony Testing Company Drug and Medical Device Testing Product Portfolio
- 7.2.5 Beijing Pony Testing Company Recent Developments
- 7.3 GTTC
- 7.3.1 GTTC Company Information
- 7.3.2 GTTC Business Overview
- 7.3.3 GTTC Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 GTTC Drug and Medical Device Testing Product Portfolio
- 7.3.5 GTTC Recent Developments
- 7.4 Shanghai International Certification Assessment Services Co.,Ltd.
- 7.4.1 Shanghai International Certification Assessment Services Co.,Ltd. Company Information
- 7.4.2 Shanghai International Certification Assessment Services Co.,Ltd. Business Overview
- 7.4.3 Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
- 7.4.5 Shanghai International Certification Assessment Services Co.,Ltd. Recent Developments
- 7.5 Guangdong Sino-sci Testing Technology Corporation Limited
- 7.5.1 Guangdong Sino-sci Testing Technology Corporation Limited Company Information
- 7.5.2 Guangdong Sino-sci Testing Technology Corporation Limited Business Overview
- 7.5.3 Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Product Portfolio
- 7.5.5 Guangdong Sino-sci Testing Technology Corporation Limited Recent Developments
- 7.6 GBT
- 7.6.1 GBT Company Information
- 7.6.2 GBT Business Overview
- 7.6.3 GBT Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 GBT Drug and Medical Device Testing Product Portfolio
- 7.6.5 GBT Recent Developments
- 7.7 FUDA TESTING GROUP
- 7.7.1 FUDA TESTING GROUP Company Information
- 7.7.2 FUDA TESTING GROUP Business Overview
- 7.7.3 FUDA TESTING GROUP Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 FUDA TESTING GROUP Drug and Medical Device Testing Product Portfolio
- 7.7.5 FUDA TESTING GROUP Recent Developments
- 7.8 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
- 7.8.1 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Company Information
- 7.8.2 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Business Overview
- 7.8.3 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
- 7.8.5 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Recent Developments
- 7.9 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
- 7.9.1 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Company Information
- 7.9.2 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Business Overview
- 7.9.3 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Product Portfolio
- 7.9.5 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Recent Developments
- 7.10 Guangzhou Medicine Industry Research Institute
- 7.10.1 Guangzhou Medicine Industry Research Institute Company Information
- 7.10.2 Guangzhou Medicine Industry Research Institute Business Overview
- 7.10.3 Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Product Portfolio
- 7.10.5 Guangzhou Medicine Industry Research Institute Recent Developments
8 North America
- 8.1 North America Drug and Medical Device Testing Revenue (2021-2032)
- 8.2 North America Drug and Medical Device Testing Revenue by Type (2021-2032)
- 8.2.1 North America Drug and Medical Device Testing Revenue by Type (2021-2026)
- 8.2.2 North America Drug and Medical Device Testing Revenue by Type (2027-2032)
- 8.3 North America Drug and Medical Device Testing Revenue Share by Type (2021-2032)
- 8.4 North America Drug and Medical Device Testing Revenue by Application (2021-2032)
- 8.4.1 North America Drug and Medical Device Testing Revenue by Application (2021-2026)
- 8.4.2 North America Drug and Medical Device Testing Revenue by Application (2027-2032)
- 8.5 North America Drug and Medical Device Testing Revenue Share by Application (2021-2032)
- 8.6 North America Drug and Medical Device Testing Revenue by Country
- 8.6.1 North America Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Drug and Medical Device Testing Revenue by Country (2021-2026)
- 8.6.3 North America Drug and Medical Device Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Drug and Medical Device Testing Revenue (2021-2032)
- 9.2 Europe Drug and Medical Device Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Drug and Medical Device Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Drug and Medical Device Testing Revenue by Type (2027-2032)
- 9.3 Europe Drug and Medical Device Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Drug and Medical Device Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Drug and Medical Device Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Drug and Medical Device Testing Revenue by Application (2027-2032)
- 9.5 Europe Drug and Medical Device Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Drug and Medical Device Testing Revenue by Country
- 9.6.1 Europe Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Drug and Medical Device Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Drug and Medical Device Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Drug and Medical Device Testing Revenue (2021-2032)
- 10.2 China Drug and Medical Device Testing Revenue by Type (2021-2032)
- 10.2.1 China Drug and Medical Device Testing Revenue by Type (2021-2026)
- 10.2.2 China Drug and Medical Device Testing Revenue by Type (2027-2032)
- 10.3 China Drug and Medical Device Testing Revenue Share by Type (2021-2032)
- 10.4 China Drug and Medical Device Testing Revenue by Application (2021-2032)
- 10.4.1 China Drug and Medical Device Testing Revenue by Application (2021-2026)
- 10.4.2 China Drug and Medical Device Testing Revenue by Application (2027-2032)
- 10.5 China Drug and Medical Device Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Drug and Medical Device Testing Revenue (2021-2032)
- 11.2 Asia Drug and Medical Device Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Drug and Medical Device Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Drug and Medical Device Testing Revenue by Type (2027-2032)
- 11.3 Asia Drug and Medical Device Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Drug and Medical Device Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Drug and Medical Device Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Drug and Medical Device Testing Revenue by Application (2027-2032)
- 11.5 Asia Drug and Medical Device Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Drug and Medical Device Testing Revenue by Country
- 11.6.1 Asia Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Drug and Medical Device Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Drug and Medical Device Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Drug and Medical Device Testing Revenue (2021-2032)
- 12.2 SAMEA Drug and Medical Device Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Drug and Medical Device Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Drug and Medical Device Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Drug and Medical Device Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Drug and Medical Device Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Drug and Medical Device Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Drug and Medical Device Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Drug and Medical Device Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Drug and Medical Device Testing Revenue by Country
- 12.6.1 SAMEA Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Drug and Medical Device Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Drug and Medical Device Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst